Obstructive Sleep Apnea (OSA)

Respiratory·MeSH: Sleep Apnea, Obstructive

Prevalence

15000.0 / 100K

Incidence

1000.0 / 100K/yr

2 drugs in development·2 companies·6 clinical trials

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Obstructive Sleep Apnea (OSA)?

BioSniper tracks 2 drugs in development for Obstructive Sleep Apnea (OSA) across 2 companies.

How many clinical trials target Obstructive Sleep Apnea (OSA)?

There are 6 clinical trials targeting Obstructive Sleep Apnea (OSA) tracked by BioSniper.

What is the prevalence of Obstructive Sleep Apnea (OSA)?

The estimated prevalence of Obstructive Sleep Apnea (OSA) is approximately 15000.0 per 100,000 population.

Deep-dive into Obstructive Sleep Apnea (OSA)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Obstructive Sleep Apnea (OSA) — Drugs in Development & Clinical Trials | BioSniper